Fuse™ Full Spectrum Endoscopy™
.
.
Find what traditional endoscopes are missing.
Colonoscopy is widely accepted as the gold standard for screening, surveillance, and
diagnosis of lower GI diseases. However, endoscopy technology has not changed
significantly in decades and interval cancers still occur1. In a tandem study using
traditional forward viewing (TFV) endoscopes, Rex et al. found they missed 24% of
the adenomas in the first colonoscopy. Since that landmark study, other technologies
have shown the miss rate for TFV to be 31%2.
How was this achieved? Traditional endoscopes provide no
more than a 170° field of view. Fuse Full Spectrum Endoscopy
provides a 330° field of view, allowing the endoscopist to see
nearly twice as much anatomy as traditional endoscopes.
In another multi-center tandem trial, the Fuse™ endoscope system demonstrated the
miss rate on adenomas with TFV was 42%. Out of 88 patients, a total of 48 adenomas
were observed. TFV identified 28 adenomas. Fuse observed an additional 20
adenomas. This means an additional 71% more adenomas were detected by Fuse
that traditional forward viewing endoscopes missed3. Conversely, when the patient
received a colonoscopy with Fuse first, followed by TFV, the researchers had an
adenoma miss rate of only 8%.
TFV
Gralnek et al.
Adenoma Miss Rate
TFV
42%
Siersema et al.
TFV
42 % Miss Rate with TFV endoscope
8% Miss Rate with Fuse endoscope
™
71
31%
% Incremental adenoma find rate
with Fuse™
Rex et al.
24%
Traditional Endoscope
Limited 170° Field of View
Fuse™ Endoscope
Full 330° Field of View
CE Marked, FDA 510(k) cleared
Gralnek et al.
8%
1997
2012
2013
2013
To schedule a Fuse experience, call your EndoChoice sales representative, or the
EndoChoice Headquarters, at 888.682.3636 x.5, or email fuse@endochoice.com.
EndoChoice.com/Fuse
(1) Rex et al. Gastroenterology 1997; (2) Siersema et al. World Journal of Gastroenterology, 2012; (3) Gralnek et al. 2013 DDW AGA/ASGE Plenary
